Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: Improved therapeutics of modified mesenchymal stem cells: an update

Fig. 2

The cycle of naïve MSCs to modified MSCs towards clinical application. The ordinary MSC is confronted with several inhospitable factors that cause it to have reduced therapeutic effect. Upon preconditioning and/or genetic modification, they gain improved therapeutic functionalities of increased injury repair and disease recovery

Back to article page